Fig. 10
From: Surface plasmon-enhanced Ag/CuS nanocomposites for cancer treatment
Viability of PC-3 cells treated with 5 and 10 % of the original Ag/CuS nanocomposites under different laser power. PC-3 cells without treatment were used as control (not shown in the figure). The Ag and Cu concentration of the original Ag/CuS nanocomposites are 13.9 and 46.6 mg/L, respectively